Metformin‐associated prevention of weight gain in insulin‐treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo‐controlled 4.3‐year trial-Reference-Cited by-同舟云学术

Metformin‐associated prevention of weight gain in insulin‐treated type 2 diabetic patients cannot be explained by decreased energy intake: A post hoc analysis of a randomized placebo‐controlled 4.3‐year trial

Published:2017-09-14 Issue:1 Volume:20 Page:219-223
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Out Mattijs¹²,Miedema Ida³,Jager‐Wittenaar Harriët³⁴,van der Schans Cees³⁵,Krijnen Wim³,Lehert Philippe⁶,Stehouwer Coen⁷^ORCID,Kooy Adriaan¹²⁸^ORCID

Affiliation:

1. Bethesda Diabetes Research Center Hoogeveen The Netherlands

2. Department of Internal MedicineBethesda General Hospital, Treant Care Group Hoogeveen The Netherlands

3. Hanze University of Applied Sciences Groningen, Research Group Healthy Ageing, Allied Health Care and Nursing Groningen The Netherlands

4. Department of Oral and Maxillofacial SurgeryUniversity of Groningen, University Medical Center Groningen Groningen The Netherlands

5. Department of Rehabilitation MedicineUniversity of Groningen, University Medical Center Groningen Groningen The Netherlands

6. Department of Statistics, Faculty of EconomicsLouvain Academy Mons Belgium

7. Department of Internal Medicine and Cardiovascular ResearchMaastricht University Medical Centre Maastricht The Netherlands

8. Department of Internal MedicineUniversity of Groningen, University Medical Center Groningen Groningen The Netherlands

Funder

LifeScan

Merck Sharp and Dohme

Novo Nordisk

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.13054

Reference16 articles.

1. Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease

2. Long-term Effects of Metformin on Metabolism and Microvascular and Macrovascular Disease in Patients With Type 2 Diabetes Mellitus

3. The effect of metformin on food intake and its potential role in hypothalamic regulation in obese diabetic rats

4. Metformin Decreases Food Consumption and Induces Weight Loss in Subjects with Obesity with Type II Non-Insulin-Dependent Diabetes

5. Effect of metformin on food intake in obese subjects

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Time course and dose effect of metformin on weight in patients with different disease states;Expert Review of Clinical Pharmacology;2020-10-02

2. Diabesity and antidiabetic drugs;Molecular Aspects of Medicine;2019-04

3. Insulin resistance is a cardiovascular risk factor in humans;Diabetes & Metabolic Syndrome: Clinical Research & Reviews;2019-03

4. Inulin and metformin ameliorate polycystic ovary syndrome via anti-inflammation and modulating gut microbiota in mice;Endocrine Journal;2019

5. A randomized, open-label, multicentre, parallel-controlled study comparing the efficacy and safety of biphasic insulin aspart 30 plus metformin with biphasic insulin aspart 30 monotherapy for type 2 diabetes patients inadequately controlled with oral anti;Diabetes, Obesity and Metabolism;2018-08-02